Cargando…

Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients

OBJECTIVE: Sorafenib is a recommended treatment for advanced hepatocellular carcinoma. The study is to evaluate the efficacy of sorafenib plus cyproheptadine compared with sorafenib alone in patients with advanced hepatocellular carcinoma. METHODS: A retrospective cohort study reviewed all consecuti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yu-Min, Feng, Chin-Wen, Lu, Chin-Li, Lee, Ming-Yang, Chen, Chi-Yi, Chen, Solomon Chih-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376992/ https://www.ncbi.nlm.nih.gov/pubmed/25646358 http://dx.doi.org/10.1093/jjco/hyv007

Ejemplares similares

CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib
por: Colagrande, S., et al.
Publicado: (2020)

Efficacy of Cyproheptadine Monotherapy in Hepatocellular Carcinoma With Bone Metastasis: A Case Report
por: Feng, Yu-Min, et al.
Publicado: (2021)

Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase
por: Feng, Yu-Min, et al.
Publicado: (2015)

Correction to: CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib
por: Colagrande, S., et al.
Publicado: (2020)

Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma
por: Hsiao, Pojen, et al.
Publicado: (2019)

Cyproheptadine-Induced Acute Liver Failure
por: Chertoff, Jason, et al.
Publicado: (2014)

Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
por: Brunetti, Oronzo, et al.
Publicado: (2019)

Hyperthermia and Serotonin: The Quest for a “Better Cyproheptadine”
por: Petroianu, Georg A.
Publicado: (2022)

Overall Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Polish Experience
por: Straś, Wojciech, et al.
Publicado: (2021)

Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma
por: Liang, Kung-Hao, et al.
Publicado: (2021)

Incapacitated Capicua in Sorafenib-Resistant HCC
por: Yin, Dingzi, et al.
Publicado: (2020)

Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy
por: Feng, Long-Hai, et al.
Publicado: (2023)

Cytotoxicity of cyproheptadine and methysergide to chemically induced carcinomas of rat colon.
por: Barkla, D. H., et al.
Publicado: (1977)

Extraction and Determination of Cyproheptadine in Human Urine by DLLME-HPLC Method
por: Maham, Mehdi, et al.
Publicado: (2013)

Preventive effect of cyproheptadine hydrochloride in refractory patients with frequent migraine
por: Okuma, Hirohisa, et al.
Publicado: (2013)

Therapeutic effect of apatinib on overall survival is mediated by prolonged progression-free survival in advanced gastric cancer patients
por: Huang, Lihong, et al.
Publicado: (2016)

Mechanism of sorafenib resistance associated with ferroptosis in HCC
por: Guo, Lingling, et al.
Publicado: (2023)

Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma
por: Jou, Yeong-Chin, et al.
Publicado: (2021)

When Too Much Is Enough: Pediatric Cyproheptadine Overdose with Confirmatory Level
por: McGovern, Terrance, et al.
Publicado: (2017)

Therapeutic cyproheptadine regimen in serotonin syndrome: Complications after cardiovascular surgery
por: Nagy, Ahmed, et al.
Publicado: (2023)

Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom
por: Palmer, D H, et al.
Publicado: (2013)

Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation
por: Lai, Hong-Yue, et al.
Publicado: (2021)

The Enhanced Metastatic Potential of Hepatocellular Carcinoma (HCC) Cells with Sorafenib Resistance
por: Chow, Ariel Ka-Man, et al.
Publicado: (2013)

Determinants of Survival and Post-Progression Outcomes by Sorafenib–Regorafenib Sequencing for Unresectable Hepatocellular Carcinoma
por: Lee, I-Cheng, et al.
Publicado: (2022)

GHR knockdown enhances the sensitivity of HCC cells to sorafenib
por: Gao, Shuang, et al.
Publicado: (2020)

Changing TACTICS in intermediate HCC: TACE plus sorafenib
por: Radu, Pompilia, et al.
Publicado: (2020)

Factors Associated with Post-Progression Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
por: Otsuka, Taiga, et al.
Publicado: (2015)

Progression-free survival as a surrogate endpoint for overall survival in patients with third-line or later-line chemotherapy for advanced gastric cancer
por: Liu, Liya, et al.
Publicado: (2015)

Progression-free or overall survival…revisited in BOLERO-2
por: Gupta, Sudeep
Publicado: (2014)

Prognostic significance of sarcopenia diagnosed based on the anthropometric equation for progression-free survival and overall survival in patients with colorectal cancer
por: Xie, Hailun, et al.
Publicado: (2023)

Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection
por: Wang, Tao, et al.
Publicado: (2020)

Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib
por: Zhang, Lei, et al.
Publicado: (2020)

Clinical Significance of the Relationship between Progression-Free Survival or Postprogression Survival and Overall Survival in Patients with Extensive Disease-Small-Cell Lung Cancer Treated with Carboplatin plus Etoposide
por: Imai, Hisao, et al.
Publicado: (2016)

Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4
por: He, Xi, et al.
Publicado: (2021)

C-reactive protein can predict dose intensity, time to treatment failure and overall survival in HCC treated with lenvatinib
por: Hayashi, Tsuguru, et al.
Publicado: (2020)

Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients with COVID-19: An Open-label, Randomized Clinical Trial
por: Boniatti, Márcio Manozzo, et al.
Publicado: (2023)

Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis
por: Chen, Yaw-Sen, et al.
Publicado: (2021)

Cabozantinib versus everolimus, nivolumab, axitinib, sorafenib and best supportive care: A network meta-analysis of progression-free survival and overall survival in second line treatment of advanced renal cell carcinoma
por: Amzal, Billy, et al.
Publicado: (2017)

Role of Baseline Albumin-Bilirubin Grade on Predict Overall Survival Among Sorafenib-Treated Patients With Hepatocellular Carcinoma in Vietnam
por: Nguyen, Thi Thu Huong, et al.
Publicado: (2019)

Overexpression of centromere protein H is significantly associated with breast cancer progression and overall patient survival
por: Liao, Wen-Ting, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cj4vna57cd1s20d60d35ll2o4s